Brown Brothers Harriman & Co’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$10.7M Buy
29,505
+3,568
+14% +$1.22M 0.05% 157
2026
Q1
$9.13M Buy
25,937
+5,453
+27% +$1.94M 0.05% 150
2025
Q4
$6.7M Buy
20,484
+2,577
+14% +$817K 0.04% 152
2025
Q3
$5.05M Sell
17,907
-686
-4% -$199K 0.03% 162
2025
Q2
$5.19M Buy
18,593
+1,025
+6% +$290K 0.03% 152
2025
Q1
$5.47M Sell
17,568
-628
-3% -$185K 0.04% 145
2024
Q4
$4.74M Sell
18,196
-2,197
-11% -$652K 0.03% 153
2024
Q3
$6.57M Sell
20,393
-59
-0.3% -$19.3K 0.04% 130
2024
Q2
$6.39M Buy
20,452
+3,555
+21% +$1.04M 0.05% 128
2024
Q1
$4.8M Buy
16,897
+241
+1% +$70.5K 0.04% 144
2023
Q4
$4.8M Buy
16,656
+161
+1% +$43.9K 0.04% 143
2023
Q3
$4.43M Sell
16,495
-74
-0.4% -$18.5K 0.04% 141
2023
Q2
$3.68M Buy
16,569
+41
+0.2% +$9.51K 0.03% 151
2023
Q1
$4M Sell
16,528
-169
-1% -$41.5K 0.03% 128
2022
Q4
$4.39M Sell
16,697
-880
-5% -$236K 0.04% 114
2022
Q3
$3.96M Sell
17,577
-459
-3% -$111K 0.04% 115
2022
Q2
$4.39M Buy
18,036
+981
+6% +$240K 0.04% 112
2022
Q1
$4.12M Buy
17,055
+152
+0.9% +$34.9K 0.03% 129
2021
Q4
$3.8K Buy
16,903
+782
+5% +$165K 0.02% 137
2021
Q3
$3.43K Sell
16,121
-1,063
-6% -$245K 0.02% 136
2021
Q2
$4.19K Sell
17,184
-430
-2% -$106K 0.02% 120
2021
Q1
$4.38K Sell
17,614
-49
-0.3% -$11.7K 0.03% 115
2020
Q4
$4.06M Buy
17,663
+1,906
+12% +$439K 0.03% 122
2020
Q3
$4M Sell
15,757
-642
-4% -$159K 0.03% 116
2020
Q2
$3.87M Buy
16,399
+4,409
+37% +$1.01M 0.03% 110
2020
Q1
$2.43M Buy
11,990
+2,416
+25% +$528K 0.02% 132
2019
Q4
$2.31M Buy
9,574
+566
+6% +$125K 0.01% 164
2019
Q3
$1.74M Buy
9,008
+4,157
+86% +$798K 0.01% 176
2019
Q2
$894K Sell
4,851
-463
-9% -$82.9K 0.01% 226
2019
Q1
$1.01M Buy
5,314
+84
+2% +$16K 0.01% 206
2018
Q4
$1.02M Sell
5,230
-2,398
-31% -$468K 0.01% 191
2018
Q3
$1.58M Buy
7,628
+603
+9% +$119K 0.01% 166
2018
Q2
$1.3M Buy
7,025
+496
+8% +$87.7K 0.01% 164
2018
Q1
$1.11M Sell
6,529
-672
-9% -$123K 0.01% 174
2017
Q4
$1.25M Sell
7,201
-20
-0.3% -$3.54K 0.01% 167
2017
Q3
$1.35M Sell
7,221
-277
-4% -$49.1K 0.01% 157
2017
Q2
$1.29M Sell
7,498
-582
-7% -$94.7K 0.01% 152
2017
Q1
$1.33M Sell
8,080
-4,369
-35% -$726K 0.01% 153
2016
Q4
$1.82M Buy
12,449
+530
+4% +$79.8K 0.01% 138
2016
Q3
$1.99M Buy
11,919
+369
+3% +$62.4K 0.01% 138
2016
Q2
$1.76M Buy
11,550
+1,153
+11% +$179K 0.01% 147
2016
Q1
$1.56M Hold
10,397
0.01% 156
2015
Q4
$1.69M Sell
10,397
-369
-3% -$58K 0.01% 155
2015
Q3
$1.49M Buy
10,766
+2,369
+28% +$373K 0.01% 162
2015
Q2
$1.29M Buy
8,397
+22
+0.3% +$3.52K 0.01% 175
2015
Q1
$1.34M Sell
8,375
-205
-2% -$32.3K 0.01% 176
2014
Q4
$1.37M Buy
8,580
+669
+8% +$104K 0.01% 174
2014
Q3
$1.11M Buy
7,911
+1,554
+24% +$203K ﹤0.01% 189
2014
Q2
$752K Sell
6,357
-2,609
-29% -$302K ﹤0.01% 228
2014
Q1
$1.11M Buy
8,966
+118
+1% +$14.3K ﹤0.01% 177
2013
Q4
$1.01M Buy
8,848
+11
+0.1% +$1.25K ﹤0.01% 182
2013
Q3
$989K Buy
8,837
+27
+0.3% +$2.93K ﹤0.01% 181
2013
Q2
$869K Buy
+8,810
New +$914K ﹤0.01% 227

Other funds holding AMGN

Brown Brothers Harriman & Co's AMGN Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Amgen (AMGN) stake by 14% in Q2 2026, buying an estimated $1.22M and bringing the position to 29,505 shares worth $10.7M. The position accounts for 0.05% of the portfolio, ranked #157.

Brown Brothers Harriman & Co first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Brown Brothers Harriman & Co held 29,505 shares of Amgen worth $10.7M as of Q2 2026.
  • Brown Brothers Harriman & Co bought 3,568 Amgen shares in Q2 2026, an estimated $1.22M.
  • Amgen made up 0.05% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #157 holding.
  • Brown Brothers Harriman & Co first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.